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Turner syndrome with spinal hemorrhage due to 
vascular malformation
Case report
Turner syndrome (TS) is a relatively common chromosomal disorder and is 
associated with a range of comorbidities involving the cardiovascular system. 
Vascular abnormalities, in particular, are a common finding in cases of TS. However, 
dissection involving the vertebral arteries is rare. Here, we report the case of a 
9-year-old girl with TS who had been treated with growth hormone replacement 
therapy for the past 3 years. She presented with weakness of both lower legs, and 
was ultimately diagnosed with spinal hemorrhage due to vascular malformation. 
We treated her with intravenous high dose dexamethasone (0.6 mg/kg) and she 
could walk without assistance after 6 days of treatment. In conclusion, when a 
patient with TS shows sudden weakness of the lower limbs, we should consider 
the possibility of spinal vessel rupture and try to take spine magnetic resonance 
imaging as soon as possible. We suggest a direction how to make a proper 
diagnosis and management of sudden vertebral artery hemorrhage in patients with 
TS.
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Introduction
Turner syndrome (TS) is a relatively common chromosomal disorder affecting approxima­
tely 1 in 2,500 live female births1). It is associated with a range of comorbidities involving the 
cardiovascular system which affects both pediatric and adult patients. Vascular abnormalities, 
including aortic dilatation, aortic dissection, aortic coarctation, aneurysm, hemangioma, and 
arteriovenous malformations, are a common finding in cases of TS2­4). In fact, incidence of 
cardiovascular anomalies in TS has been reported to be up to 45%5). Aortic dissection, which 
can occur with or without coarctation, is a rare but potentially life­threatening complication 
of TS6), however, dissection involving the vertebral arteries is rare. Here, we report the case of a 
9­year­old girl with TS who had been treated with growth hormone (GH) replacement therapy 
and developed spinal hemorrhage due to spinal vascular malformation. 
Case report
A 9­year­old girl who was previously diagnosed with TS was referred to our department 
due to weakness of both lower legs for the past 3 days. She had lymphedema at birth and 
was diagnosed with 45X/47XXX mosaic TS in the neonatal period. At the time of diagnosis, 
she received echocardiography and abdominal ultrasonography for evaluation of common 
complications in TS, and the results were all normal. She demonstrated several characteristics 
associated with TS, including high­arched palate, low hairline, low­set ears and shield chest, 
and she had been treated with GH replacement therapy for the past 3 years for management 
of her short stature. She did not have any family history of cardiovascular disease. Her father’s 
height was 176 cm, her mother’s height was 164 cm, and the midparental height was 163.5 cm. 
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Her height was 133 cm (between the 10th and 25th percentile) 
and body weight was 31.7 kg (between the 25th and 50th 
percentile). During the 3 years of GH replacement therapy, her 
height increased by as much as 16.5 cm, with a growth rate of 5.5 
cm/yr.
On presentation, her blood pressure was 97/49 mmHg and 
heart rate was 100 bpm with a regular heartbeat. Cardiac and 
chest auscultation were normal, and peripheral pulses were 
symmetric and strong. She did not have a fever or any other 
signs of infection or inflammation.
Her mental status was alert and there was no evidence of 
increased intracranial pressure. Motor function decreased to 
grade 3 in the left lower leg, and to grades 4–5 in right lower 
leg. She showed decreased dorsiflexion of the left great toe, but 
plantar flexion was intact. Lower leg sensation and deep tendon 
reflexes of both knees also were intact.
Results of  routine blood examination and coagulation 
tests were all within normal range. To rule out infection or 
inflammation, several viral studies of blood and cerebrospinal 
fluid were performed, and the results were all negative. Serum 
levels of insulin­like growth factor­1 and insulin­like growth 
factor binding protein­3 were 487.04 ng/dL and 72,000 ng/dL 
respectively, which were both within normal range according to 
her age.
Echocardiography showed no abnormalities. Brain computed 
tomography performed in the emergency department also 
showed no abnormalities. Therefore, we performed whole­spine 
magnetic resonance imaging (MRI) and spinal angiography 
(Figs. 1, 2). On the whole­spine MRI, T2­weighted images 
showed acute intradural extramedullary spinal hemorrhage 
and suspicious vascular malformation at T 11–12. On the spinal 
angiography, there was no remarkable evidence of spinal artery 
aneurysm or tumor staining.
She was treated with intravenous high dose dexamethasone 
(0.6 mg/kg) for 6 days, and gradually recovered motor func­
tion of both lower legs. On hospital day 6, she underwent 
rehabilitation for standing and walking. On hospital day 9, she 
could walk without assistance. We tapered the dexamethasone 
dose over 3 days, and then we changed to oral prednisolone 
(0.3 mg/kg). On hospital day 13, her motor function was grade 
5 in the right lower leg and grades 4–5 in left lower leg. At that 
point, she was discharged. Follow­up spine MRI performed 7 
days later, showed resolving process of the subacute intradural 
extramedullary hemorrhage and the still existing cavernous 
malformation at T 11–12 (Fig. 3). After the discharge, she had 
no problems in walking or standing, and she has been regularly 
followed up in our outpatient clinic every 6 months. There have 
been no more emerging symptoms up until her last visit.
Fig. 1. T2-weighted magnetic resonance image taken on hospital day 2, shows 
acute intradural extramedullary spinal hemorrhage (white arrow) at T 11–12.
Fig. 2. Spinal angiography taken on hospital day 2, shows no remarkable 
evidence of spinal artery aneurysm or tumor staining (white arrow). 
Fig. 3. Follow-up T2-weighted magnetic resonance image was taken 7 days after 
discharge, showing the resolving process of the subacute hemorrhage and the 
still existing suspicious cavernous malformation (white arrows) at T 11–12.
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Discussion
TS in a phenotypic female patient is characterized by short 
stature, premature ovarian failure, and congenital cardiovascular 
defects. Vascular abnormalities, including arteriovenous 
malformation, are a common finding in cases of TS2­4). However, 
spinal hemorrhage has not been reported to our knowledge.
Typical symptoms related to vertebral hemorrhage include 
neck pain, radicular pain, and myelopathy, such as quadriplegia 
or quadriparesis7), which occur due to spinal cord compression 
by the hematoma. Although it can be a neurosurgical emergency, 
some cases of  spontaneous remission after conservative 
treatment have been reported7). Given the high incidence 
of aortic dissection in TS, the possibility of cervical vessel 
dissection should be considered in patients with TS who report 
sudden weakness of the lower limbs6).
Patients with TS should be treated with recombinant human 
GH replacement therapy to increase their final height8­10). It has 
been proved that earlier initiation of GH replacement therapy 
leads to better outcome in final height10). In our case, the patient 
had been receiving GH replacement therapy for 3 years, so there 
were some concerns about the potential adverse effects of such 
therapy on cardiovascular development. However, we could 
not find a similar report or review of cardiovascular problems 
in a patient with TS. Cardiovascular problems, such as aortic 
dissection or rupture, have been reported in patients with TS 
who are receiving GH replacement therapy, but the relationship 
or causality remains unlikely9).
Spine MRI and angiography are crucial tools for diagnosis of 
vertebral hemorrhage and vertebral artery anomaly. MRI can 
detect intramural hemorrhage and demonstrate the residual 
patent lumen of the vessel. Emergent imaging techniques using 
spine MRI and angiography should be considered for proper 
detection of extracranial artery abnormalities in patients with 
TS6,9).
In this report, we described the first case of spinal hemorrhage 
in a patient with TS that was associated with suspicious vascular 
malformation. In conclusion, when a patient with TS shows 
sudden weakness of the lower limbs, we should consider the 
possibility of spinal vessel rupture and try to take spine MRI as 
soon as possible. As above, we suggest a direction how to make 
a proper diagnosis and manage the sudden vertebral artery 
hemorrhage in patients with TS.
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